Avient Past Earnings Performance
Past criteria checks 3/6
Avient's earnings have been declining at an average annual rate of -1.9%, while the Chemicals industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 2.7% per year. Avient's return on equity is 6.3%, and it has net margins of 4.6%.
Key information
-1.9%
Earnings growth rate
-3.9%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 2.7% |
| Return on equity | 6.3% |
| Net Margin | 4.6% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Avient makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 3,213 | 149 | 689 | 0 |
| 30 Jun 24 | 3,151 | 116 | 666 | 0 |
| 31 Mar 24 | 3,126 | 104 | 659 | 0 |
| 31 Dec 23 | 3,143 | 76 | 665 | 0 |
| 30 Sep 23 | 3,214 | 31 | 715 | 0 |
| 30 Jun 23 | 3,284 | -1 | 709 | 0 |
| 31 Mar 23 | 3,350 | 39 | 691 | 0 |
| 31 Dec 22 | 3,397 | 83 | 653 | 0 |
| 30 Sep 22 | 3,414 | 108 | 631 | 0 |
| 30 Jun 22 | 3,408 | 169 | 639 | 0 |
| 31 Mar 22 | 3,045 | 137 | 631 | 0 |
| 31 Dec 21 | 3,316 | 152 | 661 | 0 |
| 30 Sep 21 | 3,506 | 218 | 655 | 0 |
| 30 Jun 21 | 3,612 | 186 | 665 | 0 |
| 31 Mar 21 | 3,693 | 178 | 617 | 0 |
| 31 Dec 20 | 2,215 | 71 | 506 | 0 |
| 30 Sep 20 | 2,904 | 64 | 474 | 0 |
| 30 Jun 20 | 2,685 | 86 | 418 | 0 |
| 31 Mar 20 | 2,824 | 86 | 442 | 0 |
| 31 Dec 19 | 2,863 | 76 | 486 | 0 |
| 30 Sep 19 | 2,881 | 68 | 483 | 0 |
| 30 Jun 19 | 2,905 | 77 | 474 | 0 |
| 31 Mar 19 | 2,730 | 62 | 452 | 0 |
| 31 Dec 18 | 2,881 | 88 | 456 | 0 |
| 30 Sep 18 | 3,005 | 124 | 451 | 0 |
| 30 Jun 18 | 3,094 | 132 | 450 | 0 |
| 31 Mar 18 | 3,335 | 173 | 457 | 0 |
| 31 Dec 17 | 2,590 | 111 | 419 | 0 |
| 30 Sep 17 | 3,124 | 173 | 416 | 0 |
| 30 Jun 17 | 3,052 | 176 | 403 | 0 |
| 31 Mar 17 | 2,996 | 176 | 389 | 0 |
| 31 Dec 16 | 2,939 | 166 | 390 | 0 |
| 30 Sep 16 | 3,020 | 134 | 418 | 0 |
| 30 Jun 16 | 3,115 | 136 | 422 | 0 |
| 31 Mar 16 | 3,243 | 153 | 425 | 0 |
| 31 Dec 15 | 2,929 | 148 | 394 | 0 |
| 30 Sep 15 | 3,471 | 127 | 455 | 0 |
| 30 Jun 15 | 3,588 | 115 | 466 | 0 |
| 31 Mar 15 | 3,706 | 79 | 485 | 0 |
| 31 Dec 14 | 3,836 | 78 | 513 | 0 |
| 30 Sep 14 | 3,890 | 114 | 432 | 0 |
| 30 Jun 14 | 3,940 | 105 | 442 | 0 |
| 31 Mar 14 | 3,972 | 112 | 439 | 0 |
| 31 Dec 13 | 3,771 | 94 | 414 | 0 |
Quality Earnings: PY9 has a large one-off loss of $70.0M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: PY9's current net profit margins (4.6%) are higher than last year (1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PY9's earnings have declined by 1.9% per year over the past 5 years.
Accelerating Growth: PY9's earnings growth over the past year (380.6%) exceeds its 5-year average (-1.9% per year).
Earnings vs Industry: PY9 earnings growth over the past year (380.6%) exceeded the Chemicals industry 7.2%.
Return on Equity
High ROE: PY9's Return on Equity (6.3%) is considered low.